Result of AGM

RNS Number : 7632V

Inspecs Group PLC

11 August 2022

 

11 August 2022

Inspecs Group plc

("Inspecs" the "Company" or "the Group")

Result of AGM

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

Resolution		For		Against		Withheld	Total votes cast
		Number of votes	%	Number of votes	%	Number of votes
1.	Ordinary resolution to receive and adopt the Company's annual accounts and reports	74,283,217	86.36%	11,730,789	13.64%	2,918,304	88,932,310
2.	Ordinary resolution to declare a final dividend	88,932,210	100.00%	100	0.00%	0	88,932,310
3.	Ordinary resolution to re-elect Lord MacLaurin as a director of the Company.	70,273,568	90.69%	7,211,334	9.31%	11,447,408	88,932,310
4.	Ordinary resolution to re-elect Robin Totterman as a director of the Company.	88,932,065	100.00%	245	0.00%	0	88,932,310
5.	Ordinary resolution to re-elect Christopher Kay as a director of the Company.	88,235,979	99.22%	696,231	0.78%	100	88,932,310
6.	Ordinary resolution to re-elect Christopher Hancock as a director of the Company.	67,757,305	82.13%	14,739,869	17.87%	6,435,136	88,932,310
7.	Ordinary resolution to re-elect Richard Peck as a director of the Company.	68,126,562	82.58%	14,370,612	17.42%	6,435,136	88,932,310
8.	Ordinary resolution to re-elect Angela Farrugia as a director of the Company.	82,242,520	96.48%	3,004,273	3.52%	3,685,517	88,932,310
9.	Ordinary resolution to re-appoint Ernst & Young LLP as the Company's auditors to hold office from the conclusion of this meeting until the conclusion of the next meeting, in accordance with normal practice.	88,932,310	100.00%	0	0.00%	0	88,932,310
10.	Ordinary resolution to authorise the directors to determine the remuneration of the auditors	88,932,310	100.00%	0	0.00%	0	88,932,310
11.	Ordinary resolution to enable the Company and each of its subsidiaries to make political donations and expenditure.	87,095,027	99.33%	587,995	0.67%	1,249,288	88,932,310
12.	Ordinary resolution to authorise the directors to allot ordinary shares in the Company up to a maximum nominal amount of £338,905.08 and up to a further maximum nominal amount of £338,905.08 where the allotment is in connection with an offer by way of a rights issue.	88,932,065	100.00%	245	0.00%	0	88,932,310
13.	Special resolution to enable the directors to allot, grant options over or otherwise dispose of equity securities for cash or sell treasury shares for cash up to a maximum aggregate nominal amount of £50,835.76 as if pre-emption rights did not apply to such allotment.	87,682,777	98.60%	1,249,283	1.40%	250	88,932,310
14.	Special Resolution to further disapply pre-emption rights in relation to acquisitions or other capital investments.	87,682,777	98.60%	1,249,283	1.40%	250	88,932,310
15.	Special resolution to authorise the Company to make market purchases of up to 10,167,153 ordinary shares (which represents approximately 10 per cent of the Company's ordinary shares (excluding treasury shares) in issue on 31 December 2021).	88,932,065	100.00%	245	0.00%	0	88,932,310

For further information please contact:

Inspecs Group plc Robin Totterman (CEO) Chris Kay (CFO)	via FTI Consulting Tel: [phone]
Peel Hunt (Nominated Adviser and Broker) Adrian Trimmings Andrew Clark Lalit Bose	Tel: [phone]
FTI Consulting (Financial PR) Alex Beagley Harriet Jackson Alice Newlyn	Tel: [phone]

About Inspecs Group plc

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

INSPECS aims to be the leader in eyewear solutions through its vertically-integrated business model and has adopted a three pillar growth strategy to achieve this: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

  The Group has completed a number of significant acquisitions since its IPO in February 2020. In December 2020, INSPECS acquired Eschenbach, a leading global eyewear supplier, headquartered in Nuremberg, Germany, which includes the American company Tura. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. In December 2021 the Group acquired Ego Eyewear, a design and licensing company which uses third party eyewear manufacturers to produce premium fashion brands, and BoDe, a distributor of optical and sunglasses frames principally to the German market. 

INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 75,000 points of sale.

INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

More information is available at: https://inspecs.com  

 

END

 

 

RAGPBMITMTTBBPT